|
12 Jul 2007 |
Clinical Development Update
|
|
11 Jul 2007 |
Cell Genesys Completes Patient Recruitment for First Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
|
|
10 Jul 2007 |
Novavax Licenses Wyeth's Virus-Like Particle Technology
|
|
04 Jul 2007 |
Cytos Biotechnology reports results from phase IIa study with CYT003-QbG10 in patients suffering from atopic dermatitis
|
|
04 Jul 2007 |
MedImmune Begins Dosing Children Six Months to 24 Months of Age in Phase 1 Study of Vaccine to Help Prevent Two of the Most Common Viral Causes of Childhood Respiratory Illness
|
|
03 Jul 2007 |
Novartis enhances its vaccine pipeline by gaining access to Intercell's key technologies and vaccines programs
|
|
03 Jul 2007 |
DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC(TM)
|
|
28 Jun 2007 |
AVANT's Partner, GlaxoSmithKline, Files Rotarix(R) Application for U.S. Marketing Approval with the FDA
|
|
27 Jun 2007 |
Dynavax Starts HEPLISAV(TM) Phase 3 in Europe; U.S. Study; and Phase 2 in ESRD in Canada
|
|
22 Jun 2007 |
Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin(TM) for Multiple Sclerosis
|
|
22 Jun 2007 |
First ad35-based HIV-1 vaccine enters Phase I clinical trial at the NIH
|
|
19 Jun 2007 |
Diamyd diabetes study invalidated
|
|
19 Jun 2007 |
Phase I for Influenza vaccine adjuvanted with Intercell’s IC31(TM) started
|
|
19 Jun 2007 |
New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
|
|
18 Jun 2007 |
Hypertension vaccine CYT006-AngQb achieves strong blood
|
|
14 Jun 2007 |
Novartis gains European approval for its innovative flu vaccine Optaflu(R)
|
|
14 Jun 2007 |
GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
|
|
12 Jun 2007 |
Opexa Presents Tovaxin(TM) Research at Federation of Clinical Immunology Societies Annual Meeting
|
|
12 Jun 2007 |
Orchestra Therapeutics announces new Phase II clinical data on NeuroVAX (TM) demonstrating marked expansion of regulatory T Cell populations in patients with multiple sclerosis
|
|
08 Jun 2007 |
Mymetics' HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
|
|
07 Jun 2007 |
All patients are enrolled in Curalogic’s clinical EU phase III trial with the ragweed product
|
|
06 Jun 2007 |
Encouraging clinical activity of GSK's novel cancer immunotherapeutic confirmed in phase II study in patients with most common form of lung cancer
|
|
06 Jun 2007 |
IDM Pharma Presents Preliminary Results from Phase II UVIDEM(R) Melanoma Vaccine Clinical Trial
|
|
06 Jun 2007 |
Coley Pharmaceutical Group's Vaccine Adjuvant, VaxImmune, to Enter Phase III Clinical Testing as Part of GlaxoSmithKline's Novel Cancer Immunotherapeutic in Non-Small Cell Lung Cancer
|
|
05 Jun 2007 |
IDM Pharma Presents Interim Phase II Data From EP-2101 Lung Cancer Vaccine Clinical Trial
|
